Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsBenjamin A. Nacev, William D. Tap, Satshil Rana et al.|Nature Communications|2022Cited by 219
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 casesLiwei Jia, Ying‐Bei Chen, Maria I. Carlo et al.|Modern Pathology|2019Cited by 62
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsBenjamin A. Nacev, William D. Tap, Francisco Sánchez-Vega et al.|medRxiv|2021Cited by 14
Abstract PR012: Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targetsBenjamin A. Nacev, William Tap, Francisco Sánchez-Vega et al.|Clinical Cancer Research|2022Cited by 0